Cadilab Pharma Private Limited

Cadilab Pharma Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24230DL2022PTC397933 Incorporated 07 May 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma MSME · Micro
Data last updated
Revenue · FY 2025
₹12.16 Lakh
▼ 78% YoY
Net loss · FY 2025
₹15.14 Lakh
Net margin -124.5%
EBITDA · FY 2025
-₹14.56 Lakh
EBITDA margin -119.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Cadilab Pharma Private Limited

Data last updated:

Cadilab Pharma Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC397933. Its GSTIN is 09AAKCC2931R1Z1 (Uttar Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Anil Dubey and Ajay Tyagi.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 488 Chander Lok Street No. 3 Mandoli Road Shahdara, Delhi, India – 110093.

As per the financials filed for FY 2025, the company reported a revenue of ₹12.16 Lakh, a decline of 78% compared to the previous year. For the same year it recorded a net loss of ₹15.14 Lakh (net margin -124.5%) and EBITDA of -₹14.56 Lakh (EBITDA margin -119.8%).

Cadilab Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0054853).

Company details

CIN U24230DL2022PTC397933
Registration Number 397933
Incorporation Date 07 May 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0054853

Recognitions & Rankings of Cadilab Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-UP-29-0054853

Contact details

Cadilab Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    488 Chander Lok Street No. 3 Mandoli Road Shahdara, Delhi, India – 110093
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Cadilab Pharma Private Limited, buy the company report.

Comprehensive company report
Cadilab Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Cadilab Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Cadilab Pharma Private Limited, buy the company report.

Financials of Cadilab Pharma Private Limited

FY 2025 filings available

Cadilab Pharma Private Limited reported revenue of ₹12.16 Lakh (down 78% YoY) for FY 2025.

Revenue · FY 2025
₹12.16 Lakh ▼ 78%
Net loss · FY 2025
₹15.14 Lakh margin -124.5%
EBITDA · FY 2025
-₹14.56 Lakh margin -119.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 78%
EBITDA CAGR growth
1 year
▲ 38%

Revenue fell 78% in the latest year. EBITDA rose 38% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹14.56 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹15.14 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin-119.8%
Net Profit Margin-124.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Cadilab Pharma Private Limited, buy the company report.

Board of directors of Cadilab Pharma Private Limited

Cadilab Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anil DubeyDirector07 May 20224 Years 5 MonthsCurrent
Ajay TyagiDirector07 May 20224 Years 5 MonthsCurrent

Peer comparison

Cadilab Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Lamboria Healthcare Private Limited₹12.32 Lakh (FY 2024)-43.0%Samastipur, Bihar, India
Moseley Pharmaceuticals Private Limited₹12.2 Lakh (FY 2025)-59.0%Lucknow, Uttar Pradesh, India
Cadilab Pharma Private Limitedthis company₹12.16 Lakh (FY 2025)-₹15.14 Lakh-124.5%-78.0%Delhi, India
Tibard Pharma Private Limited (OPC)₹12.15 Lakh (FY 2018)-23.0%Fatehpur, Uttar Pradesh, India

To see the full peer comparison of Cadilab Pharma Private Limited, buy the company report.

Auditor

Cadilab Pharma Private Limited is audited by A P KUMAR & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A P KUMAR & ASSOCIATESFY 2023003028N

Shareholding

The shareholding of Cadilab Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Cadilab Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Cadilab Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Cadilab Pharma Private Limited has 1 active EPFO establishment as of Apr 10, 2024.

Active EPFO establishments
1

GST

Cadilab Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
09AAKCC2931R1Z1Uttar PradeshActive02 Jun 2022

To see the full GST registrations and return filing status of Cadilab Pharma Private Limited, buy the company report.

Recent activity

Cadilab Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Ajay Tyagi was appointed as Director on 07 May 2022.

AGM
Cadilab Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cadilab Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Ajay Tyagi was appointed as Director.
Appointed
Anil Dubey was appointed as Director.
Incorporation
07 May 2022
Cadilab Pharma Private Limited was registered on 07 May 2022 with Roc Delhi & aged 4 years 5 months as per MCA records.

Frequently asked questions

Cadilab Pharma is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 2022 (4+ years old) and is registered under CIN U24230DL2022PTC397933.

Cadilab Pharma has 2 current directors:

The latest financial statements of Cadilab Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Cadilab Pharma is 09AAKCC2931R1Z1, registered in Uttar Pradesh.

The CIN (Corporate Identification Number) of Cadilab Pharma is U24230DL2022PTC397933. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Cadilab Pharma was incorporated on 07 May 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Cadilab Pharma by revenue are Lamboria Healthcare Private Limited, Moseley Pharmaceuticals Private Limited, Tibard Pharma Private Limited (OPC), all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Ajay Tyagi was appointed as Director on 07 May 2022. Anil Dubey was appointed as Director on 07 May 2022.

Yes, Cadilab Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0054853).

The registered office of Cadilab Pharma is at 488 Chander Lok Street No. 3 Mandoli Road Shahdara, Delhi, India – 110093.

Cadilab Pharma operates in the pharma industry, in the drug formulation and development segment.